[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Biosimulation Trends: Market Research Report

December 2013 | 11 pages | ID: BEF70DCF7EAEN
Global Industry Analysts, Inc

US$ 950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Biosimulation is the mathematical simulation of complex, large biological processes on a computer. Biosimulation is being adopted at a faster pace, to extract and interpret vital data from experiments during drug discovery and development.

The report analyzes and presents an overview of Biosimulation market worldwide. The report provides global market estimates and projections for Biosimulation in US dollars for the years 2012 through 2017. Supported with 1 market data table, the report highlights the ever increasing permanence of Biosimulation. The report also provides a review of Biosimulation Models, and Biosimulation software. In addition, 36 companies operating in the Dye Sensitized Cells arena worldwide including Accelrys Inc., Entelos Inc., Rhenovia Pharma SAS and others are profiled.
1. BIOSIMULATION – A MARKET OVERVIEW

A Prelude

Table 1. Global Biosimulation Market (2012-2017) in US$ Million

Biosimulation - Revolutionizing Drug Discovery
Biosimulation - Models
Biosimulation Software

2. RECENT INDUSTRY ACTIVITY

Accelrys Introduces Discovery Studio 3. 5
Rhenovia Pharma Introduces Drug Development Programs for Orphan, Neglected and Rare Neurodegenerative Diseases
Rhenovia Pharma Sets Up International Subsidiary in the US
Rhenovia Pharma Inks an Agreement with Portmann
Entelos and RegeneMed Introduce iToxFX Service

3. MARKET PARTICIPANTS

Accelrys, Inc. (USA)
Advanced Chemistry Development, Inc. (Canada)
Anoixis Corporation (USA)
Aptiv Solutions (USA)
Archimedes, Inc. (USA)
Certara LP (USA)
Chemical Computing Group, Inc. (Canada)
Cognigen Corporation (USA)
Compugen Ltd. (Israel)
Entelos, Inc. (USA)
Genedata AG (Switzerland)
GNS Healthcare (USA)
Immunetrics, Inc. (USA)
In Silico Biosciences, Inc. (USA)
InhibOx Ltd. (UK)
INOSIM Software GmbH (Germany)
Insilico Biotechnology AG (Germany)
Kinetigen, Inc. (USA)
LeadInvent (India)
Leadscope, Inc. (USA)
Molecular Knowledge Systems, Inc. (USA)
Nimbus Discovery LLC (USA)
Novo Nordisk A/S (Denmark)
Open Eye Scientific Software, Inc. (USA)
Optimata Ltd. (Israel)
PhinC Development (France)
Physiomics PLC (UK)
Rhenovia Pharma SAS (France)
Rosa & Company LLC (USA)
Schrodinger LLC (USA)
Simcyp Ltd. (UK)
Simulations Plus, Inc. (USA)
Synergix Ltd. (Israel)
Tessella Ltd. (UK)
TheraSim (USA)
VirtuCel, Inc. (USA)

4. APPENDIX


More Publications